EPHB4 and neoplasm: As expected, sEphB4-HSA markedly reduced EphB4 phosphorylation (Figure 3B), indicating sEphB4-HSA gained access to EphB4 expressing on tumor cells and inhibited EphB4 signaling in vivo.